Evaluation of EZSCAN as a screening tool for impaired glucose metabolism

Diabetes Research and Clinical Practice

Volumn 100, Issue 2, 2013, Pages 210-214

  Chen, Lizhu ^a   Chen, Xiaolu ^a   Ding, Rongjing ^b   Shi Jr , Qiuting ^c   Hu, Dayi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c Xianghe Chinese Medicine Hospital   (China)

Author keywords

EZSCAN; Impaired glucose metabolism; Receiver operating characteristic curve

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISORDERS OF CARBOHYDRATE METABOLISM; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE METABOLISM; IMPAIRED GLUCOSE TOLERANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING; SENSITIVITY AND SPECIFICITY; SKIN CONDUCTANCE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 84878371408     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.03.001     Document Type: Article

References (24)

1. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362(12):1090-1101.
2. Salas-Salvado J., Martinez-Gonzalez M.A., Bullo M., Ros E. The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 2011, 21(Suppl. 2):B32-B48.
3. Lindström J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemiö K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368(9548):1673-1679.
4. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6):393-403.
5. TabáK A.G., Herder C., Rathmann W., Brunner E.J., Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012, 379(9833):2279-2290.
6. Schwarz P., Brunswick P., Calvet J.H. EZSCAN™ a new technology to detect diabetes risk. Br J Diabetes Vasc Med 2011, 11(4):204-209.
7. Vinik A.I., Mason R.E., Mitchell B.D., Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003, 26(5):1553-1579.
8. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60(1):108-111.
9. Putz Z., Tabák A.G., Tóth N., Istenes I., Németh N., Gandhi R.A., et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009, 32(1):181-183.
10. Grandinetti A., Chow D., Sletten M., Oyama J., Theriault A., Schatz I., et al. Impaired glucose tolerance is associated with postganglionic sudomotor impairment. Clin Auton Res 2007, 17(4):231-233.
11. Mayaudon H., Miloche P.O., Bauduceau B. A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 2010, 36(6 Pt 1):450-454.
12. Ramachandran A., Moses A., Shetty S., Thirupurasundari C.J., Seeli A.C., Snehalatha C., et al. A new non-invasive technology to screen for dysglycaemia including diabetes. Diabetes Res Clin Pract 2010, 88(3):302-306.
13. Sheng C.S., Zeng W.F., Huang Q.F., Deslypere J.P., Li Y., Wang J.G. Accuracy of a novel non-invasive technology based EZSCAN system for the diagnosis of diabetes mellitus in Chinese. Diabetol Metab Syndr 2011, 3(1):36.
14. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl. 1):S11-S61.
15. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
16. World Health Organization Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus [guideline on the Internet]; 1999.
17. Anselmino M., Malmberg K., Mellbin L., Rydén L. Overview of the importance of glycaemic control for cardiovascular events in the in-and-out patient setting. Rev Endocr Metab Disord 2010, 11(1):87-94.
18. Ambady R., Chamukuttan S. Early diagnosis and prevention of diabetes in developing countries. Rev Endocr Metab Disord 2008, 9(3):193-201.
19. Sun K., Liu Y., Dai M., Li M., Yang Z., Xu M., et al. Accessing autonomic function can early screen metabolic syndrome. PLoS One 2012, 7(8):e43449.
20. Ramachandran A., Moses A., Snehalatha C., Shetty S., Seeli A.C., Singvi S., et al. Assessment of sudomotor for function of predict future abnormalities of glucose tolerance in at risk population. J Diabetes Metab 2011, 2(3):1-4.
21. Schwarz P.E., Li J., Lindstrom J., Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009, 41(2):86-97.
22. Tankova T., Chakarova N., Atanassova I., Dakovska L. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract 2011, 92(1):46-52.
23. Makrilakis K., Liatis S., Grammatikou S., Perrea D., Stathi C., Tsiligros P., et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab 2011, 37(2):144-151.
24. Papanas N, Boulton AJ, Malik RA, Manes C, Schnell O, Spallone V, et al. Neuropad®: a simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med [Epub 2012 August 25].